Bill Would Cut Use Of 30-Month Stay In Drug Suits
Senate bill 2300, the “Lower Priced Drugs Act,” is intended to stem suspected abuse by the pharmaceutical industry of the 30-month stay. The stay is often granted to prevent approval of generic drugs by the U.S. Food and Drug Administration until the lawsuit is resolved.
The bill would also cut in...
To view the full article, register now.